BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/26/2024 2:07:30 PM | Browse: 215 | Download: 485
 |
Received |
|
2023-11-05 14:08 |
 |
Peer-Review Started |
|
2023-11-06 03:52 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-12-04 19:18 |
 |
Revised |
|
2023-12-14 08:36 |
 |
Second Decision |
|
2024-01-29 02:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-01-29 02:28 |
 |
Articles in Press |
|
2024-01-29 02:28 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-01-26 03:44 |
 |
Typeset the Manuscript |
|
2024-02-20 01:14 |
 |
Publish the Manuscript Online |
|
2024-02-26 13:28 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Editorial |
Article Title |
Immunotherapy of gastric cancer: Present status and future perspectives
|
Manuscript Source |
Invited Manuscript |
All Author List |
John K Triantafillidis, Manousos M Konstadoulakis and Apostolos E Papalois |
Funding Agency and Grant Number |
|
Corresponding Author |
Apostolos E Papalois, DPhil, Adjunct Professor, Unit of Surgical Research and Training, Second Department of Surgery, University of Athens, School of Medicine, Aretaieion Hospital, 76 Vas Sophias Avenue, Athens 11528, Attica, Greece. apostolospapalois@gmail.com |
Key Words |
Gastric cancer; Chemotherapy; Immunotherapy; Immune checkpoint inhibitors; Bibliometrics; Scientometrics |
Core Tip |
Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide. Conservative treatment in the form of chemotherapy has recently made remarkable advances, particularly in the field of immunotherapy. Immunotherapy of GC represents one of the most important fields of research worldwide today, particularly in China, the United States, and Japan, as well as in some Western European countries. Several treatment regimens have been approved and are being implemented with satisfactory results. Also, several treatment regimens are currently under investigation, which are expected to improve the disappointing prognosis of this malignant neoplasm. |
Publish Date |
2024-02-26 13:28 |
Citation |
Triantafillidis JK, Konstadoulakis MM, Papalois AE. Immunotherapy of gastric cancer: Present status and future perspectives. World J Gastroenterol 2024; 30(8): 779-793 |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i8/779.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i8.779 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345